Syamal Roy

Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions

Arun Kumar Haldar, Pradip Sen, Syamal Roy · Molecular Biology International · 2011 · 404 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains of <i>Leishmania donovani</i> That Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis

Rajatava Basu, Suniti Bhaumik, Jayati Basu et al. · The Journal of Immunology · 2005 · 243 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Leishmania donovani Targets Dicer1 to Downregulate miR-122, Lower Serum Cholesterol, and Facilitate Murine Liver Infection

June Ghosh, Mainak Bose, Syamal Roy et al. · Cell Host & Microbe · 2013 · 193 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent

Hideo Imamura, Tim Downing, Frederik Van den Broeck et al. · eLife · 2016 · 188 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in<i>Leishmania donovani</i>-Infected Macrophages

Jayati Basu, Ananda Mookerjee, Prosenjit Sen et al. · Antimicrobial Agents and Chemotherapy · 2006 · 175 citations · Full text

Life Sciences, Immunology, Pharmacology +17